ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Juluca 50 mg, Filmtabletten - 30
66790001 ViiV Healthcare GmbH
Juluca 50 mg, Filmtabletten06.12.2018
  06.12.2018
Dolutegravir and Rilpivirine (J05AR21) 
WHO-DDD 
08.03.30
08.03. 
A  
Yes 
IPCI
855.65No
    
10 %947.00
  
7680667900016Synthetika
7637930 
Composition
dolutegravirum 50 mg ut dolutegravirum natricum 52.62 mg, rilpivirinum 25 mg ut rilpivirini hydrochloridum 27.5 mg, mannitolum, cellulosum microcristallinum, povidonum K 29-32, carboxymethylamylum natricum, natrii stearylis fumaras, lactosum monohydricum 55.15 mg, carmellosum natricum conexum, povidonum K 30, polysorbatum 20, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 4.61 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Dolutegravirum50 mg
Rilpivirinum25 mg
BAG: Active AgentDose
Dolutegravirum50 mg
Rilpivirinum25 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Carboxymethylamylum Natricum  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
Cellulosum Microcristallinum Silicificatum  
E 171 color.
E 172 color.
Lactose Monohydrate55.15 mg 
Macrogol  
Magnesii Stearas  
Mannitol  
Natrii Stearylis Fumaras  
Poly(Alcohol Vinylicus) Überzug
Polysorbatum 20  
Povidonum K30  
Pro Compresso Obducto  
Talcum  
 
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home